GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » BibbInstruments AB (XSAT:BIBB) » Definitions » ROE % Adjusted to Book Value

BibbInstruments AB (XSAT:BIBB) ROE % Adjusted to Book Value : -14.19% (As of Dec. 2024)


View and export this data going back to 2017. Start your Free Trial

What is BibbInstruments AB ROE % Adjusted to Book Value?

BibbInstruments AB's ROE % for the quarter that ended in Dec. 2024 was -49.65%. BibbInstruments AB's PB Ratio for the quarter that ended in Dec. 2024 was 3.50. BibbInstruments AB's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2024 was -14.19%.


BibbInstruments AB ROE % Adjusted to Book Value Historical Data

The historical data trend for BibbInstruments AB's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BibbInstruments AB ROE % Adjusted to Book Value Chart

BibbInstruments AB Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
ROE % Adjusted to Book Value
Get a 7-Day Free Trial Premium Member Only Premium Member Only -7.67 -5.01 -10.80 -13.00 -12.19

BibbInstruments AB Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
ROE % Adjusted to Book Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -14.81 -9.68 -9.02 -7.70 -14.19

Competitive Comparison of BibbInstruments AB's ROE % Adjusted to Book Value

For the Medical Devices subindustry, BibbInstruments AB's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


BibbInstruments AB's ROE % Adjusted to Book Value Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, BibbInstruments AB's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where BibbInstruments AB's ROE % Adjusted to Book Value falls into.


;
;

BibbInstruments AB ROE % Adjusted to Book Value Calculation

BibbInstruments AB's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2024 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=-42.65% / 3.50
=-12.19%

BibbInstruments AB's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2024 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=-49.65% / 3.50
=-14.19%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


BibbInstruments AB ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of BibbInstruments AB's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.


BibbInstruments AB Business Description

Traded in Other Exchanges
N/A
Address
Scheelevagen 2, Medicon Village, Lund, SWE, SE-223 81
BibbInstruments AB develops disposable biopsy instrumentation under the brand EndoDrill for early detection of cancer tumors, especially in deep-tissue tumors. The product portfolio includes six disposable instruments based on the patented EndoDrill technology and a novel biopsy method still under development. The instruments will be used for tissue sampling (biopsy) of the most common types of cancer, for example; lung, breast, colorectal, prostate and stomach cancer.

BibbInstruments AB Headlines

No Headlines